Navigation Links
Generex Oncology Awarded Two IRS Therapeutic Discovery Project Grants
Date:11/10/2010

WORCESTER, Mass., Nov. 10, 2010 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTC Bulletin Board: GNBT) announced today that its wholly-owned immunotherapeutics subsidiary, Antigen Express, Inc. (www.antigenexpress.com), has been awarded two Therapeutic Discovery Project grants, totaling $488,958.50, by the United States Internal Revenue Service (IRS) and the Department of Health and Human Services (HHS) pursuant to the Patient Protection and Affordable Care Act of 2010.

The Antigen Express Therapeutic Discovery Projects are entitled:

  • Ii-Key Her-2/neu Peptide Vaccine, for the treatment of breast cancer
  • Ii-Key Her-2/neu Peptide Vaccine, for the treatment of prostate cancer

The proprietary vaccine being developed by Antigen Express is an off-the-shelf product designed to reduce the risk of relapse in cancer patients.  It is the subject of a controlled, randomized Phase II trial in patients with breast cancer which has yielded positive interim results.  Based on positive results from a Phase I trial in prostate cancer patients, preparations for a Phase II clinical trial in prostate cancer patients are underway.  In all studies, the self-potentiating vaccine has shown very low toxicity and generates a good immune response.  

The Therapeutic Discovery Project grants are targeted for projects that show a reasonable potential to: result in new therapies to treat areas of unmet medical need or prevent, detect, or treat chronic or acute diseases and conditions; reduce the long-term growth of health care costs in the United States; or, significantly advance the goal of curing cancer within 30 years.  Grant allocations also take into consideration which projects s
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Generex Common Stock Now Quoted on the Over-the-Counter Bulletin Board
2. Generex to Participate in Canadian Diabetes Association Conference
3. Generex Reschedules Live Video Webcast
4. Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date
5. Generex Announces That Adjournment Will be Sole Matter Considered at Reconvened Special Meeting of Stockholders on October 15, 2010
6. Generex Provides Clarification for Special Meeting Voting
7. Generex Reaches Agreement to Acquire 51% Stake in Global Medical Direct, a Nationwide Durable Medical Equipment and Pharmaceutical Provider Specializing in Direct-to-Consumer Diabetes Supplies
8. Generex Biotechnology Provides a Corporate Update to Address Managements Strategic Initiatives for Growth
9. Generex Awarded a New Patent in Canada for its Proprietary Buccal Drug Delivery System
10. Generex Presents Abstract at EASD Annual Meeting
11. Generex Announces Sales Agreement with Elias Shaker & Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... SHANGHAI , Oct. 22, 2014 ... ) and WuXi PharmaTech (Cayman) Inc. (NYSE: ... Medicine,s comprehensive genomic profiling to biopharmaceutical companies conducting clinical ... Under the terms of the collaboration, Foundation Medicine ... component of Foundation Medicine,s FoundationOne® assay at the WuXi ...
(Date:10/20/2014)... octubre de 2014  PneumRx, Inc. ( www.pneumrx.com ... pulmonología intervencional, anunció hoy la conclusión de la ... antes de lo programado. El Estudio Clínico RENEW es ... investigación (IDE) aprobada por la FDA (Administración de ... de reducción de volumen pulmonar PneumRx RePneu, un ...
(Date:10/20/2014)... Colo. , Oct. 20, 2014  Luoxis ... (NYSE MKT: AMPE), today announced that its academic ... clinical and research potential for its novel RedoxSYS ... potential (ORP) in the body in response to ... value of ORP as a clinical marker will ...
Breaking Medicine Technology:Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 2Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 3Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 4Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 5PneumRx concluye inscripción en prueba fundamental RENEW 2PneumRx concluye inscripción en prueba fundamental RENEW 3Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 2Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 3Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 4Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 5
... Feb. 28, 2012 eCardio Diagnostics ( www.ecardio.com ... monitoring, today announced the acceptance for publication of ... Telemetry to Improve Diagnostic Accuracy and Enable More ... Arrhythmia Section of US Cardiology journal,s ...
... N.M., Feb. 28, 2012   New Mexico Software, Inc. , ... NMXC ), a developer of medical IT solutions ... healthcare community, announced today that the company,s long standing suit ... with judgment in favor of New Mexico Software. ...
Cached Medicine Technology:eCardio Announces Publication of Manuscript on The Use of Mobile Cardiac Telemetry to Improve Diagnostic Accuracy and Enable More Efficient Patient Care 2eCardio Announces Publication of Manuscript on The Use of Mobile Cardiac Telemetry to Improve Diagnostic Accuracy and Enable More Efficient Patient Care 3New Mexico Software Prevails in Lawsuit 2
(Date:10/22/2014)... On October 22, CBS will air an ... both fictional and real. The Charles E Holman ... to advocacy and philanthropy in the battle against Morgellons ... to impart truth and clarity about this misunderstood and ... misconceptions about Morgellons Disease (MD) and most ...
(Date:10/22/2014)... News) -- The United States is now mandating ... of West Africa land at one of five ... the virus. In a statement released Tuesday, ... percent of air passengers from Guinea, Liberia and ... five airports -- New York City,s Kennedy International ...
(Date:10/22/2014)... 2014 During the Western United States’ ... runs dangerously low, Southern Oregon’s water is proving resistant ... the lowest mountain snow pack on record in 2014, ... early autumn.* That was the observation of journalist-hikers Art ... “Hiking Southern Oregon,” during an interview with water advocate ...
(Date:10/22/2014)... 22, 2014 Lintelus, Inc., an event ... President of Sales, will be speaking on the subject ... Expo on October 28, at the Holiday Inn in ... booth as well as a Tech Demo at 12:45pm, ... create a more engaging event experience. , The Annual ...
(Date:10/22/2014)... 21, 2014 (HealthDay News) -- Two sisters in high ... damage. Ilina and Medha Krishen use electronic stethoscopes, ... of trouble in breathing patterns or heartbeats. Ilina, ... Michigan, wanted to find a way to detect early ... Using an electronic stethoscope, Ilina recorded one breath cycle ...
Breaking Medicine News(10 mins):Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 3Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 2Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 2Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 4Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2
... Feb. 17 CryoLife, Inc. (NYSE: CRY ... today,that the U.S. Food and Drug Administration (FDA) has ... heart valve. The new labeling claim,relates to reducing ... the,CryoValve SG. , CryoValve SG ...
... Will ensure at least 99.99 percent uptime ... 17 Stratus Technologies, Inc. announced that ... interactive patient communication systems, has adopted the ... as a technology foundation for its flagship ...
... Event Marks 20th Anniversary of the HBA,s Prestigious Industry ... Businesswomen,s Association (HBA) today announced that its 2009 "Woman ... Chief Executive Officer of Millennium: The Takeda Oncology Company."I ... and medicine to transform cancer from a dreaded killer ...
... decisions, study says , , MONDAY, Feb. 16 (HealthDay News) -- ... they prescribe cancer medications for uses beyond what the drugs ... According to the report, published in the Feb. 17 ... online and hard-copy resource used by oncologists and pharmacists, known ...
... Feb. 17 RediClinic announced today that it has,received ... (CCA) Quality and Safety Standards by the Jefferson School ... Board of Directors adopted 10 Quality and Safety Standards ... and accrediting,organizations, as well as its Clinical Advisory Board. ...
... Perry,s Donation to Fund Renovation of Crisis ShelterATLANTA, ... Covenant House Georgia announced today that writer/director/producer Tyler ... 15-passenger van to the Atlanta-based homeless shelter. ... the complete renovation of its Crisis Shelter for ...
Cached Medicine News:Health News:FDA Clears New Immune Response Claim for the CryoValve(R) SG Pulmonary Human Heart Valve 2Health News:FDA Clears New Immune Response Claim for the CryoValve(R) SG Pulmonary Human Heart Valve 3Health News:Stratus Technologies Signs Allen Technologies as Newest Channel Partner for High Availability Avance Software 2Health News:Stratus Technologies Signs Allen Technologies as Newest Channel Partner for High Availability Avance Software 3Health News:Healthcare Businesswomen's Association Announces 2009 Woman of the Year, Dr. Deborah Dunsire, President and CEO of Millennium: The Takeda Oncology Company 2Health News:Healthcare Businesswomen's Association Announces 2009 Woman of the Year, Dr. Deborah Dunsire, President and CEO of Millennium: The Takeda Oncology Company 3Health News:Healthcare Businesswomen's Association Announces 2009 Woman of the Year, Dr. Deborah Dunsire, President and CEO of Millennium: The Takeda Oncology Company 4Health News:Doctors' Guide to Cancer Drugs May Need Revising 2Health News:RediClinic Meets Strict Quality and Safety Standards for Retail Clinics 2Health News:RediClinic Meets Strict Quality and Safety Standards for Retail Clinics 3Health News:RediClinic Meets Strict Quality and Safety Standards for Retail Clinics 4Health News:Tyler Perry Donates $110K to Covenant House Keeping Atlanta Teens off the Street 2
... to its design, this is the ... stone therapy in urinary and biliary ... a multipurpose lithotripter with other applications ... nephrolithotomy. ,The basic system comprises the ...
All the power and performance of the STS - T but now available with a stand-alone 9" II C-Arm...
... The Compact Sigma is designed to ... Quick, precise mechanical coupling eliminates clumsy ... be performed as well. Dorniers patented ... too. ,Positioning is simple using the ...
The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean...
Medicine Products: